Flamand L, Romerio F, Reitz M S, Gallo R C
Laboratory of Virology, Rheumatology and Immunology Research Center, Centre de Recherche du CHUL and Laval University, Sainte-Foy, Quebec, Canada.
J Virol. 1998 Nov;72(11):8797-805. doi: 10.1128/JVI.72.11.8797-8805.1998.
The observation that human herpesvirus 6 (HHV-6) can induce CD4 gene transcription and expression in CD4(-) cells was reported several years ago (P. Lusso, A. De Maria, M. Malnati, F. Lori, S. E. DeRocco, M. Baseler, and R. C. Gallo, Nature 349:533-535, 1991) and subsequently confirmed (P. Lusso, M. S. Malnati, A. Garzino-Demo, R. W. Crowley, E. O. Long, and R. C. Gallo, Nature 362:458-462, 1993; G. Furlini, M. Vignoli, E. Ramazzotti, M. C. Re, G. Visani, and M. LaPlaca, Blood 87:4737-4745, 1996). Our objective was to identify the mechanisms underlying such phenomena. Using reporter gene constructs driven by the CD4 promoter, we report that HHV-6 can efficiently transactivate such genetic elements. Activation of the CD4 promoter occurs in the presence of the viral DNA polymerase inhibitor phosphonoformic acid, which limits expression to the immediate-early and early classes of viral genes. Using deletion mutants and specific CD4 promoter mutants, we identified an ATF/CRE binding site located at nucleotides -67 to -60 upstream of the CD4 gene transcription start site that is important for HHV-6 transactivation. The ATF/CRE site is also essential for CD4 promoter activation by forskolin, an activator of adenylate cyclase. Using electrophoretic mobility shift assays and specific antibodies, we showed that CREB-1 binds specifically to the -79 to -52 region of the CD4 promoter. Last, we have identified two open reading frames (ORFs) of HHV-6, U86 and U89 from the immediate-early locus A, that can transactivate the CD4 promoter in HeLa cells. However, transactivation of the CD4 promoter by ORFs U86 and U89 is independent of the CRE element, suggesting that additional HHV-6 ORFs are likely to contribute to CD4 gene activation. Taken together, our results will help to understand the complex interactions occurring between HHV-6 and the CD4 promoter and provide additional information regarding the class of transcription factors involved in the control of CD4 gene expression.
数年前有报道称人类疱疹病毒6型(HHV - 6)可在CD4(-)细胞中诱导CD4基因转录和表达(P. Lusso、A. De Maria、M. Malnati、F. Lori、S. E. DeRocco、M. Baseler和R. C. Gallo,《自然》349:533 - 535,1991),随后得到证实(P. Lusso、M. S. Malnati、A. Garzino - Demo、R. W. Crowley、E. O. Long和R. C. Gallo,《自然》362:458 - 462,1993;G. Furlini、M. Vignoli、E. Ramazzotti、M. C. Re、G. Visani和M. LaPlaca,《血液》87:4737 - 4745,1996)。我们的目标是确定此类现象背后的机制。利用由CD4启动子驱动的报告基因构建体,我们报告HHV - 6可有效反式激活此类遗传元件。CD4启动子的激活发生在存在病毒DNA聚合酶抑制剂膦甲酸的情况下,膦甲酸将表达限制在病毒基因的即刻早期和早期类别。利用缺失突变体和特定的CD4启动子突变体,我们在CD4基因转录起始位点上游核苷酸 - 67至 - 60处鉴定出一个ATF/CRE结合位点,该位点对HHV - 6反式激活很重要。ATF/CRE位点对于由腺苷酸环化酶激活剂福斯可林介导的CD4启动子激活也至关重要。利用电泳迁移率变动分析和特异性抗体,我们表明CREB - 1特异性结合CD4启动子的 - 79至 - 52区域。最后,我们从即刻早期基因座A鉴定出HHV - 6的两个开放阅读框(ORF),U86和U89,它们可在HeLa细胞中反式激活CD4启动子。然而,ORF U86和U89对CD4启动子的反式激活不依赖于CRE元件,这表明可能还有其他HHV - 6 ORF对CD4基因激活有贡献。综上所述,我们的结果将有助于理解HHV - 6与CD4启动子之间发生的复杂相互作用,并提供有关参与CD4基因表达调控的转录因子类别的更多信息。